Cargando…
How to Effectively Identify Patients With Rifampin-Resistant Tuberculosis in China: Perspectives of Stakeholders Among Service Providers
To evaluate China's current rifampin-resistant tuberculosis (RR-TB) screening strategy from stakeholders' perspectives, the perceptions, attitudes, and interests of 245 stakeholders from three eastern, central, and western China provinces on RR-TB screening strategies, were investigated th...
Autores principales: | Hua, Qianhui, Xu, Hong, Chen, Xinyi, Pan, Junhang, Peng, Ying, Wang, Wei, Chen, Bin, Jiang, Jianmin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8651999/ https://www.ncbi.nlm.nih.gov/pubmed/34900894 http://dx.doi.org/10.3389/fpubh.2021.736632 |
Ejemplares similares
-
Evaluation of a High-Intensity Green Fluorescent Protein Fluorophage Method for Drug- Resistance Diagnosis in Tuberculosis for Isoniazid, Rifampin, and Streptomycin
por: Yu, Xia, et al.
Publicado: (2016) -
Systemic Fairness for Sharing Health Data: Perspectives From Swiss Stakeholders
por: Geneviève, Lester Darryl, et al.
Publicado: (2021) -
Perspectives of Stakeholders of Equitable Access to Community Naloxone Programs: A Literature Review
por: Martignetti, Lucas, et al.
Publicado: (2022) -
Development of telemedicine in the Czech Republic from patients’ and other key stakeholders’ perspective
por: Těšinová, Jolana Kopsa, et al.
Publicado: (2023) -
Factors determining the quality of health services provided to COVID-19 patients from the perspective of healthcare providers: Based on the Donabedian model
por: Moayed, Malihe Sadat, et al.
Publicado: (2022)